InsidersTradesSigma
Follow the 보령 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 보령 has recorded 45 insider filings. Market capitalisation: €686.8bn. The latest transaction was disclosed on 16 March 2026 (Other). Among the most active insiders: 보령파트너스. Every trade is accessible without an account.
45
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,951 of 29,053 companies
68.7
score / 100
Value82
Quality55
FCF yld15%
Earn yld9.4%
EV/EBITDA8.1x
ROE13%
Gross mgn37%
Net mgn6.3%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 March 2026
Declarations45 total
25 of 45 declarations
关于 보령
Boryung 是一家在XKRX市场上市的医疗保健和制药公司。它专注于药品的开发和商业化。